Sinus Lifting
Conditions
Keywords
Transcrestal sinus lifting, erythropoitein, albumin PRF, Peizo electric device, Dental implants, CBCT.
Brief summary
Background: Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence trans crestal sinus lifting with albumin platelet rich plasma. Aim of the study: To compare between erythropoietin and albumin platelet rich fibrin transcrestal sinus lifting versus albumin platelet rich fibrin transcrestal sinus lifting using piezoelectric device in patients with atrophic maxilla. Methods: This study will be carried out as a randomized
Interventions
OTHERErythropoietin and albumin PRF gel + implant placement
This group will be treated by transcrestal sinus lifting with erythropoietin and albumin PRF gel with simultaneous implant placement.
OTHERAlbumin PRF gel +implant placement
This group (the Control group) will be treated with transcrestal sinus lifting using albumin PRF gel, with simultaneous implant placement.
Sponsors
Alexandria University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Residual bone height not less than 5 mm measured from crestal bone to sinus floor. * Both genders. * Good oral hygiene * No previous surgery or radiation treatment on the maxillary sinus
Exclusion criteria
* Recent radiation therapy in maxilla. * Uncontrolled systemic diseases such as diabetes mellitus. * Heavy smoker (those who smoke ≥ 25 cigarettes a day). * Alcohol abuse. * Patient on anticoagulant drug * Severe allergic rhinitis. * Tumor or large cyst in the maxillary sinus. * Oroantral fistula. * Presence of acute or chronic sinus pathoses or sinus membrane perforation.(
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in pain scores | up to 14 days | pain will be assessed through a 10 point visual analogue scale (VAS). (0-1=none, 2-4=mild, 5-7=moderate, 8-10=severe). |
| Change in edema | up to 14 days | Edema will be assessed as follows: 1. None (no swelling) 2. Mild (intraoral swelling confined to the surgical field) 3. Moderate (extra oral swelling in the surgical zone) 4. Severe (extraoral swelling spreading beyond the surgical zone) |
| Change in implant stability | immediate and 4 months | implant stability will be assessed using ostell device |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in bone gain | baseline and 4 months | amount of sinus bone gain (SBG) which equals implant protrusion length (IPL) added to Peri-implant sinus bone level (PSBL) which is the distance between the apex of the implant and sinus bone level |
| Change in bone density | baseline and 4 months | it will be assessed using CBCT |
Countries
Egypt
Contacts
Primary ContactHassan M Ruzyqat, BDS
Outcome results
None listed